세계의 유전자형 분석 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Genotyping Assay Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

US $ 3,920 ￦ 5,638,000

PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 4,730 ￦ 6,803,000

PDF & Excel (10-user License)

PDF 및 Excel 보고서를 동일 기업 내 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 7,430 ￦ 10,686,000

PDF & Excel (Corporate User License)

PDF 및 Excel 보고서를 동일 기업 내 모든 사용자가 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

한글목차

세계의 유전자형 분석 시장은 2025-2033년 연평균 복합 성장률(CAGR) 23.01%로 성장할 것으로 예측되며 현저한 확대가 예상됩니다. 시장 분석에 따르면 시장 규모는 2024년 420억 달러에서 2033년 말 2,708억 7,000만 달러에 이를 것으로 예측됩니다.

세계의 유전자형 분석 시장은 맞춤형 의료, 약리 유전체학, 질병 연구에 있어서 용도 증가에 견인되어 급속한 성장을 이루고 있습니다. 높은 처리량 시퀀싱, 마이크로어레이 기술, CRISPR 기반 분석의 기술 혁신으로 정확성, 속도 및 비용 효율성이 향상되었습니다. 향후 개발은 종합적인 유전체 분석을 위한 다중화 기능, 자동화, 바이오인포매틱스 플랫폼과의 통합에 초점을 맞출 것입니다.

또한 유전성 질환 및 암 유병률 상승과 연구 자금 확대가 시장 수요를 밀어 올리고 있습니다. 직접 소비자에게 제공되는 유전자 검사와 동반자 진단의 성장은 최종 사용자 계층을 확대하고 있습니다. 규제 프레임워크 및 데이터 프라이버시에 대한 배려가 분석 개발과 상업화를 형성하고 있습니다. 유전체학의 진보에 따라, 유전자형 분석 시장은 진화를 계속하고 정확하고 확장 가능하며 임상적으로 적절한 솔루션을 제공할 것입니다.

목차

제1장 서문

제2장 주요 요약

• 시장의 하이라이트
• 세계 시장 현황

제3장 유전자형 분석 : 산업 분석

• 서문 : 시장 역학
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 업계 동향
• Porter's Five Forces 분석
• 시장 매력 분석

제4장 밸류체인 분석

• 밸류체인 분석
• 원재료 분석
  • 원재료 리스트
  • 원재료 제조업체 리스트
  • 주요 원재료의 가격 동향
• 잠재적 구매자 목록
• 마케팅 채널
  • 직접 마케팅
  • 간접 마케팅
  • 마케팅 채널 발전 동향

제5장 세계의 유전자형 분석 시장 분석 : 제품 및 서비스별

• 개요 : 제품 및 서비스별
• 과거 및 예측 데이터 분석 : 제품 및 서비스별
• 시약 및 키트
• 유전자형 서비스
• 기기
• 바이오인포매틱스

제6장 세계의 유전자형 분석 시장 분석 : 기술별

• 개요 : 기술별
• 과거 및 예측 데이터 분석 : 기술별
• PCR법
• 마이크로어레이
• 시퀀싱
• 모세관 전기 영동
• MALDI-TOF
• 기타(알레르 특이적 올리고뉴클레오티드(ASO) 프로브, 형광 in situ 하이브리드화(FISH) 등)

제7장 세계의 유전자형 분석 시장 분석 : 용도별

• 개요 : 용도별
• 과거 및 예측 데이터 분석 : 용도별
• 파마코 유전체학
• 진단 및 맞춤형 의료
• 농업 생명공학
• 동물 유전학
• 기타(출생 전 검사, 인간 법의학, 미생물 유전체 연구, 수산 양식 번식 연구 등)

제8장 세계의 유전자형 분석 시장 분석 : 최종 사용자별

• 개요 : 최종 사용자별
• 과거 및 예측 데이터 분석 : 최종 사용자별
• 제약 및 바이오 의약품 기업
• 진단 및 조사 연구소
• 학술기관
• 기타(동물 및 수산회사 등)

제9장 세계의 유전자형 분석 시장 분석 : 지역별

• 지역별 전망
• 서문
• 북미의 매출 분석
  • 개요, 분석 및 예측
  • 북미 : 부문별
  • 북미 국가별
  • 미국
  • 캐나다
  • 멕시코
• 유럽의 매출 분석
  • 개요, 분석 및 예측
  • 유럽 : 부문별
  • 유럽 국가별
  • 영국
  • 프랑스
  • 독일
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양의 매출 분석
  • 개요, 분석 및 예측
  • 아시아태평양 : 부문별
  • 아시아태평양 국가별
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주
  • 동남아시아
  • 기타 아시아태평양
• 라틴아메리카의 매출 분석
  • 개요, 분석 및 예측
  • 라틴아메리카 : 부문별
  • 라틴아메리카 국가별
  • 브라질
  • 아르헨티나
  • 페루
  • 칠레
  • 기타 라틴아메리카
• 중동 및 아프리카의 매출 분석
  • 개요, 분석 및 예측
  • 중동 및 아프리카 : 부문별
  • 중동 및 아프리카 국가별 일람
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 남아프리카
  • 기타 중동 및 아프리카

제10장 유전자형 분석 기업 경쟁 구도

• 유전자형 분석 시장의 경쟁
• 파트너십, 제휴 및 합의
• 합병 및 인수
• 신제품 출시
• 기타 개발

제11장 기업 프로파일

• 주요 기업의 시장 점유율 분석
• 시장 집중도
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN NV
• Agilent Technologies Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• GE HealthCare Technologies Inc.
• Standard BioTools Inc.
• PerkinElmer Inc.
• Eurofins Scientific SE
• Bio-Rad Laboratories Inc.
• Pacific Biosciences Of California Inc.
• GENEWIZ Inc.
• Integrated DNA Technologies Inc

AJY

영문 목차

영문목차

Global Genotyping Assay Market is anticipated to experience remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 23.01% from 2025 to 2033. According to the market analysis, the market size is forecasted to reach USD 270.87 Billion by the end of 2033, up from USD 42 Billion in 2024.

The global genotyping assay market is experiencing rapid growth driven by increasing applications in personalized medicine, pharmacogenomics, and disease research. Innovations in high-throughput sequencing, microarray technologies, and CRISPR-based assays are enhancing accuracy, speed, and cost-effectiveness. Future developments will focus on multiplexing capabilities, automation, and integration with bioinformatics platforms for comprehensive genomic analysis.

Additionally, rising prevalence of genetic disorders and cancer, coupled with expanding research funding, is propelling market demand. The growth of direct-to-consumer genetic testing and companion diagnostics is broadening end-user segments. Regulatory frameworks and data privacy considerations are shaping assay development and commercialization. As genomics advances, the genotyping assay market will continue to evolve, delivering precise, scalable, and clinically relevant solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Genotyping Assay market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

• Reagents & Kits
• Genotyping Services
• Instruments
• Bioinformatics

By Technology

• PCR
• Microarrays
• Sequencing
• Capillary Electrophoresis
• MALDI-TOF
• Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)

By Application

• Pharmacogenomics
• Diagnostic & Personalized Medicine
• Agricultural Biotechnology
• Animal Genetics
• Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)

By End-user

• Pharmaceutical & Biopharmaceutical Companies
• Diagnostic & Research Laboratories
• Academic Institutes
• Others (Animal and Aquagenetics Companies, etc.)
• List of Companies Profiled in the report
• Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Agilent Technologies Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., Standard BioTools Inc., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., Pacific Biosciences of California Inc., Genewiz Inc., Integrated DNA Technologies Inc

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. GENOTYPING ASSAY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product & Service
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End-user
  • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY PRODUCT & SERVICE

• 5.1. Overview By Product & Service
• 5.2. Historical and Forecast Data Analysis By Product & Service
• 5.3. Reagents & Kits Historic and Forecast Sales By Regions
• 5.4. Genotyping Services Historic and Forecast Sales By Regions
• 5.5. Instruments Historic and Forecast Sales By Regions
• 5.6. Bioinformatics Historic and Forecast Sales By Regions

6. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY TECHNOLOGY

• 6.1. Overview By Technology
• 6.2. Historical and Forecast Data Analysis By Technology
• 6.3. PCR Historic and Forecast Sales By Regions
• 6.4. Microarrays Historic and Forecast Sales By Regions
• 6.5. Sequencing Historic and Forecast Sales By Regions
• 6.6. Capillary Electrophoresis Historic and Forecast Sales By Regions
• 6.7. MALDI-TOF Historic and Forecast Sales By Regions
• 6.8. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.) Historic and Forecast Sales By Regions

7. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Pharmacogenomics Historic and Forecast Sales By Regions
• 7.4. Diagnostic & Personalized Medicine Historic and Forecast Sales By Regions
• 7.5. Agricultural Biotechnology Historic and Forecast Sales By Regions
• 7.6. Animal Genetics Historic and Forecast Sales By Regions
• 7.7. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.) Historic and Forecast Sales By Regions

8. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY END-USER

• 8.1. Overview By End-user
• 8.2. Historical and Forecast Data Analysis By End-user
• 8.3. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
• 8.4. Diagnostic & Research Laboratories Historic and Forecast Sales By Regions
• 8.5. Academic Institutes Historic and Forecast Sales By Regions
• 8.6. Others (Animal and Aquagenetics Companies, etc.) Historic and Forecast Sales By Regions

9. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE GENOTYPING ASSAY COMPANIES

• 10.1. Genotyping Assay Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF GENOTYPING ASSAY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Illumina Inc.
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Thermo Fisher Scientific Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. QIAGEN N.V.
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Agilent Technologies Inc.
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Danaher Corporation
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. F. Hoffmann-La Roche Ltd
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. GE HealthCare Technologies Inc.
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Standard BioTools Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. PerkinElmer Inc.
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Eurofins Scientific SE
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Bio-Rad Laboratories Inc.
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Pacific Biosciences Of California Inc.
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. GENEWIZ Inc.
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. Integrated DNA Technologies Inc
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

관련자료